RetractedArticleDrug design, development and therapy2015

The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.

Jin-Ping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.